Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)

por Argyriou, Andreas A.
Publicado 2015

The effect of stimulation technique on sympathetic skin responses in healthy subjects

por Chroni, Elisabeth, Argyriou, Andreas A., Polychronopoulos, Panagiotis, Sirrou, Vassiliki
Publicado 2006

Promises and hurdles of undergraduate medical development in Greece

por Ifanti, Amalia A, Argyriou, Andreas A, Kalofonos, Haralabos P
Publicado 2011

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity

por Velasco, Roser, Alemany, Montserrat, Villagrán, Macarena, Argyriou, Andreas A.
Publicado 2021

Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis

por Dermitzakis, Emmanouil V., Vikelis, Michail, Vlachos, George S., Argyriou, Andreas A.
Publicado 2022

Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine

por Dermitzakis, Emmanouil V., Vikelis, Michail, Vlachos, George S., Argyriou, Andreas A.
Publicado 2022

OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine

por Argyriou, Andreas A., Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Vikelis, Michail
Publicado 2022

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

por Argyriou, Andreas A, Kyritsis, Athanasios P, Makatsoris, Thomas, Kalofonos, Haralabos P
Publicado 2014

Pneumococcal Otogenic Meningitis Complicated With Pneumocephalus and Coma State

por Liourdi, Despoina, Litsardopoulos, Pantelis, Dimitropoulou, Dimitra, Fatourou, Adrianni, Argyriou, Andreas A
Publicado 2020

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors

por Vilariño, Noelia, Bruna, Jordi, Kalofonou, Foteini, Anastopoulou, Garifallia G., Argyriou, Andreas A.
Publicado 2020

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

por Vikelis, Michail, Argyriou, Andreas A., Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Mitsikostas, Dimos D.
Publicado 2016

Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence

por Park, Susanna B, Cetinkaya-Fisgin, Aysel, Argyriou, Andreas A, Höke, Ahmet, Cavaletti, Guido, Alberti, Paola
Publicado 2023

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

por Vikelis, Michail, Argyriou, Andreas A., Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Makris, Nikolaos, Kararizou, Evangelia
Publicado 2018

Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of migr...

por Dermitzakis, Emmanouil V., Kouroudi, Aikaterini, Argyriou, Andreas A., Spingos, Konstantinos C., Bilias, Konstantinos, Vikelis, Michail
Publicado 2022

Neurological Complications of Conventional and Novel Anticancer Treatments

por Alberti, Paola, Salvalaggio, Alessandro, Argyriou, Andreas A., Bruna, Jordi, Visentin, Andrea, Cavaletti, Guido, Briani, Chiara
Publicado 2022

Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction...

por Dermitzakis, Emmanouil V., Kouroudi, Aikaterini, Argyriou, Andreas A., Spingos, Konstantinos C., Bilias, Konstantinos, Vikelis, Michail
Publicado 2022

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Regi...

por Argyriou, Andreas A., Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Rallis, Dimitrios, Soldatos, Panagiotis, Litsardopoulos, Pantelis, Vikelis, Michail
Publicado 2023

Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up

por Xiromerisiou, Georgia, Lampropoulos, Ioannis C., Dermitzakis, Emmanouil V., Vikelis, Michail, Marogianni, Chrysoula, Mysiris, Dimitrios, Argyriou, Andreas A.
Publicado 2023

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registr...

por Vikelis, Michail, Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Rallis, Dimitrios, Soldatos, Panagiotis, Litsardopoulos, Pantelis, Rikos, Dimitrios, Argyriou, Andreas A.
Publicado 2023

Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Pro...

por Vikelis, Michail, Dermitzakis, Emmanouil V., Vlachos, George S., Soldatos, Panagiotis, Spingos, Konstantinos C., Litsardopoulos, Pantelis, Kararizou, Evangelia, Argyriou, Andreas A.
Publicado 2020